FDA so­lic­its in­dus­try in­put for OND pol­i­cy pri­or­i­ties

A Fri­day FDA no­tice is so­lic­it­ing pol­i­cy sug­ges­tions from the in­dus­try that re­view staff at the FDA’s Of­fice of New Drugs (OND) can im­ple­ment in the near fu­ture.

To hear from in­dus­try on “spe­cif­ic, ac­tion­able pol­i­cy sug­ges­tions that could be im­ple­ment­ed in the near-term,” the FDA is so­lic­it­ing pre­sen­ta­tions for dis­cus­sions at a pub­lic meet­ing set via the Fed­er­al Reg­is­ter no­tice as well as invit­ing com­ments on the top­ics that the no­tice dis­cuss­es.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.